EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The association between acute transverse myelitis and COVID ‐19 vaccination in Korea: Self‐controlled case series study

Eunsun Lim iD, Yoo Hwan Kim, Na-Young Jeong, Su-Hyun Kim iD, Heehyun Won, Jong-Seok Bae iD, Nam-Kyong Choi, COVID‐19 Vaccine Safety Committee (CoVaSC).

European Journal of Neurology · 2025

DOI: 10.1111/ene.70020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Eunsun Lim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Convergence, College of Science and Industry Convergence, Ewha Womans University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Myelitis, Transverse, COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was conducted by the COVID-19 Vaccine Safety Research Committee (CoVaSC), a division under the National Academy of Medicine of Korea (NAMOK), with g…, Korea Centers for Disease Control and Prevention.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute transverse myelitis (ATM) has been reported as a potential association between COVID‐19 vaccination. In this study, we aimed to investigate the association between the COVID‐19 vaccination and ATM.

Methods

A self‐controlled case series study was performed using a large database that combine the COVID‐19 vaccine registry and the national claims database. The COVID‐19 vaccination data included information on individuals aged 18 and above who received COVID‐19 vaccination from February 26, 2021, to August 31, 2022. The claims database covered the entire Korean population for the period between January 1, 2002 to August 31, 2022. Patients who develop ATM within 1–42 days following COVID‐19 vaccination were included. The observation period was 270 days after the first dose of the COVID‐19 vaccine. The incidence rate ratio (IRR) and 95% confidence interval (CI) were estimated using a conditional Poisson regression model.

Results

A total of 159 ATM patients were included. Among them, 82 (51.6%) were male, and mean age was 55.4 (±17.4) years. The IRR was 2.41 (95% CI: 1.76–3.30) for the ATM risk within 1–42 days after COVID‐19 vaccination. The IRR by vaccine product was 3.31 (95% CI: 1.81–6.05) for ChAdOx1‐S; 1.99 (95% CI: 1.30–3.03) for BNT162b2; 2.57 (95% CI: 1.14–5.97) for mRNA‐1273; and 3.33 (95% CI: 0.30–36.44) for Ad26.COV2.S.

Conclusion

These findings indicated an increased risk of ATM following COVID‐19 vaccination within 42 days. An association with the risk of ATM was found both for viral vector and mRNA vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelitis, TransverseCOVID-19 VaccinesCOVID-19HumansMaleFemaleMiddle AgedRepublic of KoreaAdultAgedVaccination

Stichwörter der Autor:innen

COVID‐19adverse eventsself‐controlled case seriestransverse myelitisvaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Health Convergence, College of Science and Industry Convergence, Ewha Womans University, Seoul, Republic of Korea.
  • Department of Neurology, Hallym University Sacred Heart Hospital, College of Medicine, Hallym Universit, Anyang, Republic of Korea.
  • Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Republic of Korea.
  • Department of Neurology, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Republic of Korea.
  • Graduate School of Industrial Pharmaceutical Science, College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea.

ORCID-Profile: Eunsun Lim, Su-Hyun Kim, Jong-Seok Bae

Förderung

  • This study was conducted by the COVID-19 Vaccine Safety Research Committee (CoVaSC), a division under the National Academy of Medicine of Korea (NAMOK), with g…
  • Korea Centers for Disease Control and Prevention

Zitieren

APA

Lim, E., Kim, Y. H., Jeong, N. Y., Kim, S. H., Won, H., Bae, J. S., Choi, N. K., & COVID‐19 Vaccine Safety Committee (CoVaSC). (2025). The association between acute transverse myelitis and COVID ‐19 vaccination in Korea: Self‐controlled case series study. European Journal of Neurology. https://doi.org/10.1111/ene.70020

Vancouver

Lim E, Kim YH, Jeong NY, Kim SH, Won H, Bae JS, et al. The association between acute transverse myelitis and COVID ‐19 vaccination in Korea: Self‐controlled case series study. European Journal of Neurology. 2025. doi:10.1111/ene.70020

BibTeX
@article{Lim2025,
  author = {Lim, Eunsun and Kim, Yoo Hwan and Jeong, Na-Young and Kim, Su-Hyun and Won, Heehyun and Bae, Jong-Seok and Choi, Nam-Kyong and COVID‐19 Vaccine Safety Committee (CoVaSC)., COVID‐19 Vaccine Safety Committee (CoVaSC).},
  title = {The association between acute transverse myelitis and COVID ‐19 vaccination in Korea: Self‐controlled case series study},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70020}
}
Kostenlos starten →